|SEQ_NO||1||Date of announcement||2020/06/11||Time of announcement||14:48:09|
|Subject||Announcement of TTY Biopharm's unaudited income information in May 2020|
|Date of events||2020/06/11||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/06/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $267,055 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $49,307 thousands, and a consolidated income before tax of $69,731 thousands in May 2020; net income attributed to stockholders of the company was $60,990 thousands; EPS is $0.25.
Year-to-date consolidated net sales was $1,716,528 thousands (in NT dollars; unaudited), a consolidated operating profit was $432,201 thousands and consolidated income before tax was $492,435 thousands until May 2020; year-to-date net income attributed to stockholders of the company was $391,733 thousands; EPS is $1.58.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.